Research Article
Therapeutic Effects and Metabolic Spectrum of Traditional Chinese Medicine Hengqing II Prescription on Alzheimer’s Disease
Table 2
The comparison of scale tests before and 1 month and 3 months after HQII and donepezil hydrochloride treatment in AD patients.
| Scale tests | Control group | HQII group | Before treatment | 1 month after treatment | 3 months after treatment | Before treatment | 1 month after treatment | 3 months after treatment |
| MoCA score | 17.26 ± 2.16 | 19.11 ± 2.22 | 23.57 ± 3.03 | 16.72 ± 4.21 | 22.58 ± 5.37 | 26.14 ± 2.10 | ADAS-Cog score | 34.8 ± 4.7 | 31.0 ± 3.5 | 29.6 ± 4.3 | 34.3 ± 3.6 | 29.1 ± 3.2 | 25.2 ± 3.1 | ADL score | 41.5 ± 5.6 | 37.2 ± 2.5 | 35.7 ± 3.7 | 40.2 ± 4.3 | 35.5 ± 3.7 | 29.5 ± 3.4 | PSP score | 45.63 ± 5.97 | 51.21 ± 14.37 | 67.84 ± 14.75 | 45.74 ± 6.15 | 59.44 ± 15.88 | 81.45 ± 16.62 | CMAI score | 46.92 ± 8.49 | 41.37 ± 7.62 | 37.23 ± 6.38 | 47.89 ± 8.67 | 38.22 ± 7.21 | 30.45 ± 6.34 |
|
|
Compared with the Control group after 3 months of treatment, . |